How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,854 results for

Tongue Carcinoma

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1701. Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer

and systemic paclitaxel and carboplatin in patients with recurrent squamous cell carcinoma of the head and neck. II. Determine the safety of this regimen in this patient population. III. Determine the time to progression, pattern of progression, and rate of relapse of patients treated with this regimen. VI. Determine the time to response and duration of response of patients treated with this regimen. V. Determine the overall survival of patients treated with this regimen. OUTLINE: This is a multicenter (...) Given In Combination With Systematic Chemotherapy Paclitaxel And Carboplatin In The Treatment Of Patients With Squamous Cell Carcinoma Of The Head And Neck At First Relapse Study Start Date : November 2000 Resource links provided by the National Library of Medicine related topics: related topics: available for: resources: Arms and Interventions Go to Outcome Measures Go to Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important

2001 Clinical Trials

1702. Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx

Ages Eligible for Study: 15 Years to 80 Years (Child, Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria DISEASE CHARACTERISTICS: Histologically or cytologically confirmed squamous cell or poorly differentiated carcinomas, or lymphoepithelioma of the head and neck Stage III carcinoma of the base of the tongue or hypopharynx Stage IV carcinoma of the oral cavity, pharynx (including nasopharynx, oropharynx, and hypopharynx), or larynx No distant metastasis (...) carcinoma of the lip and oral cavity stage IV squamous cell carcinoma of the lip and oral cavity stage IV squamous cell carcinoma of the oropharynx stage IV lymphoepithelioma of the oropharynx stage IV squamous cell carcinoma of the nasopharynx stage IV lymphoepithelioma of the nasopharynx stage III squamous cell carcinoma of the hypopharynx stage IV squamous cell carcinoma of the hypopharynx stage IV squamous cell carcinoma of the larynx Additional relevant MeSH terms: Layout table for MeSH terms Head

1999 Clinical Trials

1703. A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer

Neoplasm Squamous Cell Carcinoma Drug: paclitaxel concurrent with radiation therapy Phase 1 Detailed Description: This is a pilot study designed to evaluate the toxicity of a five day infusion of Paclitaxel concurrent with radiation therapy for advanced head and neck cancers. Patients with previously untreated Stage III and IV squamous cell cancer (SCC) of the oral cavity, oropharynx, hypopharynx, nasopharynx, larynx and maxillary sinus, as well as Stage II SCC of the base of the tongue, nasopharynx (...) for eligibility information Ages Eligible for Study: Child, Adult, Older Adult Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria INCLUSION CRITERIA Patients must satisfy the following criteria: The patient must have a biopsy proven diagnosis of carcinoma of the oral cavity, oropharynx, hypopharynx, nasopharynx, larynx, maxillary sinus. Squamous cell, lymphoepithelioma, transitional cell and undifferentiated histologies will be included. We will accept AJCC stages III-IV for all the sites

1999 Clinical Trials

1704. Clinical report on the L95P mutation in a Dutch family with paraganglioma. (PubMed)

at the age of 34 years, a T4 planocellular carcinoma of the tongue occurred within the previous radiation field 27 years later, when the patient was 61 years old. Volume measurements of three untreated glomus tumors (two glomus vagale tumors, one glomus caroticum tumor) during 25 months showed an increase in two tumors (left glomus caroticum, left glomus vagale tumor) and a decrease in one tumor (right glomus vagale tumor). Surgery to remove two bilateral and one unilateral glomus caroticum tumors (...) was successful. A wait-and-see policy is being applied to two glomus vagale tumors.In family members of paraganglioma 1 patients, mutation analysis can be used to make an early diagnosis of glomus tumors. Radiotherapy may have induced a carcinoma. Modalities of treatment can include a wait-and-see policy. Long-term follow-up studies on the natural course of glomus tumors are needed to improve decisions about treatment modalities.

2002 Otology and Neurotology

1705. Erosive pustular dermatosis of the leg: report of three cases. (PubMed)

for erosive pustular dermatosis. The lesions rapidly responded to topical treatment with either tacrolimus or corticosteroids. Of note, this condition was associated with a diverticular disease in two patients, while in another patient an epidermoid carcinoma of the tongue was present. Erosive pustular dermatosis of the leg is an uncommon but distinct skin disorder typically associated with trophic changes of the lower limbs. Our observations raise the question of the relation of erosive pustular

2002 British Journal of Dermatology

1706. [Risk factors of late complications after interstitial 192Ir brachytherapy in cancers of the oral cavity]. (PubMed)

[Risk factors of late complications after interstitial 192Ir brachytherapy in cancers of the oral cavity]. Brachytherapy has confirmed its prevailing role in conservative treatment of oral cavity carcinomas. To describe late toxicity in long-term surviving patients, comparisons with other series are necessary. Study of series of patients implanted for floor of the mouth or mobile tongue shows the need for more detailed data. Dental prophylaxy and lead protection of the mandibule, good

1998 Cancer radiothérapie : journal de la Société française de radiothérapie oncologique

1707. Clinical significance of radiation therapy combined with chemotherapy. (PubMed)

Clinical significance of radiation therapy combined with chemotherapy. With the aim of reducing the side-effects in the surrounding healthy tissues, and/or improving the local control rate, radiotherapy combined with chemotherapy has been used to treat carcinoma of the esophagus, of the tongue, and of the paranasal sinuses. In the treatment of esophageal cancer, a dose of bleomycin too small to demonstrate clinical activity on its own is shown to potentiate the action of radiation (...) with an enhancement ratio lying between 1.3 and 1.7 (Table 1). From the concept of 'therapeutic ratio' a 'two-phase' treatment modality (Table 2) was proposed, because many anticancer drugs or radiosensitizers available today influence not only the tumor tissue but also the surrounding healthy tissues. 'Two-phase' treatment was applied to cancer of the tongue (Table 3) and to cancer of the paranasal sinuses (Table 4). The appearance of the chronical complications such as the osteoradionecrosis of the mandible

1980 Strahlentherapie Controlled trial quality: uncertain

1708. Induction chemotherapy in primary resectable head and neck tumors - a prospective randomized trial. (PubMed)

of the hypopharynx and base of tongue is too small for a statistically significant statement, but preliminary data indicate a better overall and disease-free survival without chemotherapy in these patients. Therefore, we recommend controlled trials with induction chemotherapy in patients with primary resectable carcinomas of the oral cavity and the tonsil, stages T2-T3 and N0-N2, prior to surgery but not in patients with cancer of the hypopharynx and base of the tongue. (...) of carboplatin/5-FU prior to surgery and radiotherapy (arm A, 49 patients) or standard treatment with surgery and radiotherapy (arm B, 47 patients). Patients were stratified by primary tumor site and neck disease. After a follow-up of 12-48 months overall survival was 72% in arm A and 53% in arm B (n.s.). Considering only the patients with cancer of the oral cavity and the tonsil overall survival was 88% in arm A and 44% in arm B (p<0.05). As of today, the number of patients with carcinomas

1994 International journal of oncology Controlled trial quality: uncertain

1709. Oculocutaneous manifestations in xeroderma pigmentosa. (PubMed)

Oculocutaneous manifestations in xeroderma pigmentosa. Xeroderma pigmentosum (XP) is a rare genetic disease characterised by defective DNA repair leading to clinical and cellular hypersensitivity to ultraviolet radiation. The oculocutaneous features of 10 patients with XP were studied retrospectively. General features included parental consanguinity (40%), familiarity (60%), onset of symptoms in first 2 years (50%), malignant skin neoplasms (60%), and carcinoma of the tongue (20%). Among (...) the ocular features, 50% of patients presented with photophobia. Lid freckles or atrophic skin lesions were seen in all patients. Lower lid tumours were seen in 30%, chronic conjunctival congestion in 40%, corneal opacification in 40%, squamous cell carcinoma of limbus in 20%, bilateral pterygium in 40%, and visual impairment in 50%. The clinical features (ocular and cutaneous) of the cases are discussed.

Full Text available with Trip Pro

1994 The British journal of ophthalmology

1710. The first 15 cm are important in upper gastrointestinal endoscopy. (PubMed)

The first 15 cm are important in upper gastrointestinal endoscopy. 8343634 1993 09 07 2008 11 20 0959-8138 306 6894 1993 Jun 26 BMJ (Clinical research ed.) BMJ The first 15 cm are important in upper gastrointestinal endoscopy. 1742 Rai A S AS Southampton General Hospital. Steer H H eng Case Reports Journal Article England BMJ 8900488 0959-8138 AIM IM Carcinoma, Squamous Cell complications Endoscopy, Gastrointestinal methods Gastrointestinal Hemorrhage etiology Humans Male Middle Aged Tongue

Full Text available with Trip Pro

1993 BMJ : British Medical Journal

1711. Malignancy of the larynx: (Experimentation on Animal, Construction of Biologic Neo-Larynx and Rehabilitation of the Laryngectomee—20 Years Experience) (PubMed)

Malignancy of the larynx: (Experimentation on Animal, Construction of Biologic Neo-Larynx and Rehabilitation of the Laryngectomee—20 Years Experience) Squamous cell carcinoma is by far the commonest malignancy of the larynx and I would confine my present paper mainly to this along with the management and post-operative rehabilitation after total laryngectomy. High survival rate in majority of the cases, if diagnosed and treated early and adequately, provokes and encourages the interested (...) knowledge) and a Neo-Glottis are ingeniously constructed in order to enable the laryngectomee to phonate tracheooesophageally (c.f. pharyngoesophageally). The Neo-Glottis is transversely disposed since it offers better protection against aspiration than the vertically disposed one. The Neo-Epiglottis is constructed from the posterior tracheal wall, inferiorly based, or from the superiorly based tongue-shaped flap, raised from the full-thickness membranous posterior tracheal wall, or from the anterior

Full Text available with Trip Pro

1997 Indian Journal of Otolaryngology and Head & Neck Surgery

1712. Oral cancer (PubMed)

Oral cancer 11342519 2001 08 30 2018 11 13 0093-0415 174 5 2001 May The Western journal of medicine West. J. Med. Oral cancer. 348-51 Scully C C Eastman Dental Institute for Oral Health Care Sciences, University College London, University of London, 256, Gray's Inn Road, London, WC1X 8LD, UK. c.scully@eastman.ucl.ac.uk Porter S S eng Journal Article United States West J Med 0410504 0093-0415 AIM IM Biopsy, Needle Carcinoma, Squamous Cell diagnosis mortality therapy Combined Modality Therapy (...) Female Humans Lip Neoplasms diagnosis therapy Male Mouth Neoplasms diagnosis mortality therapy Prognosis Radiotherapy methods Surgical Procedures, Operative methods Survival Rate Tongue Neoplasms diagnosis therapy 2001 5 9 10 0 2001 8 31 10 1 2001 5 9 10 0 ppublish 11342519 PMC1071397 Oral Dis. 1999 Jul;5(3):206-9 10483065 J Am Dent Assoc. 1999 Oct;130(10):1445-57 10570588 J Craniomaxillofac Surg. 1999 Jun;27(3):187-91 10442311 Br J Oral Maxillofac Surg. 1999 Jun;37(3):164-74 10454022 Crit Rev Oncol

Full Text available with Trip Pro

2001 Western Journal of Medicine

1713. [Intra-arterial preoperative chemotherapy versus preoperative radiotherapy]. (PubMed)

. Germany Strahlenther Onkol 8603469 0179-7158 0 Antibiotics, Antineoplastic 0 Antineoplastic Agents 3Z8479ZZ5X Epirubicin Q20Q21Q62J Cisplatin IM Antibiotics, Antineoplastic administration & dosage Antineoplastic Agents administration & dosage Carcinoma, Squamous Cell drug therapy radiotherapy surgery Carotid Artery, External Chemotherapy, Adjuvant Cisplatin administration & dosage Combined Modality Therapy Epirubicin administration & dosage Follow-Up Studies Humans Infusions, Intra-Arterial Mouth (...) Floor Mouth Neoplasms drug therapy radiotherapy surgery Neoplasm Recurrence, Local prevention & control Odds Ratio Osteoradionecrosis etiology Preoperative Care Quality of Life Radiotherapy adverse effects Radiotherapy Dosage Radiotherapy, Adjuvant Surveys and Questionnaires Time Factors Tongue Neoplasms drug therapy radiotherapy surgery 2001 3 10 10 0 2001 4 3 10 1 2001 3 10 10 0 ppublish 11233834

2001 Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] Controlled trial quality: uncertain

1714. [Sparing normal oral tissues with individual dental stent in radiotherapy for primary nasopharyngeal carcinoma patients]. (PubMed)

[Sparing normal oral tissues with individual dental stent in radiotherapy for primary nasopharyngeal carcinoma patients]. With the progression of radiotherapy techniques, the 5-year overall survival rate of nasopharyngeal carcinoma (NPC) patients has increased obviously. As the survival time prolonged, more and more attention was paid to various radiation sequelae and the quality of life of the patients. This study was to explore the role of individual dental stent in sparing normal oral (...) tissues for primary NPC patients in radiotherapy by pushing the tongue and a part of oral mucous membrane away from the radiation fields.Irradiation dose and volume of the tongue of a NPC patient before and after wearing dental stent was evaluated. A total of 43 patients were randomized into 2 groups: 19 in trial group and 24 in control group. Trial group wore dental stent during radiotherapy, while control group did not. Patients' weight, taste, oral mucous reaction, and tongue mucous reaction before

2007 Ai zheng = Aizheng = Chinese journal of cancer Controlled trial quality: uncertain

1715. Thyroid papillary carcinoma arising in ectopic thyroid tissue within a neck branchial cyst (PubMed)

Thyroid papillary carcinoma arising in ectopic thyroid tissue within a neck branchial cyst Thyroid gland derives from one median anlage at the base of the tongue, and from the two fourth branchial pouches. A number of anomalies may occur during their migration. These can be in form of ectopic tissues, which are frequently found along the course of thyroglossal duct and rarely in other sites, many of these may develop same diseases as the thyroid gland.A 36-years-old female presented with a 3 (...) month history of left side neck mass. The mass disappeared following aspiration of brown colored fluid, which on cytological examination showed cells with nuclear irregularities that warranted the resection of the lesion. The histology demonstrated a thyroid papillary carcinoma arising within the branchial cyst. Thereafter, the patient underwent a total thyroidectomy with central lymph nodes dissection. Histology showed a multifocal papillary carcinoma with central lymph nodes metastases. Only four

Full Text available with Trip Pro

2006 World journal of surgical oncology

1716. Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients

Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00201383 Recruitment Status : Completed First Posted : September 20, 2005

2005 Clinical Trials

1717. Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma

Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Chemoprevention Study of Oral Cavity (...) Squamous Cell Carcinoma The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00201279 Recruitment Status : Completed First Posted : September 20, 2005 Last Update Posted : September 20, 2005 Sponsor: National Health Research Institutes, Taiwan Collaborators: National Taiwan University Hospital Changhua

2005 Clinical Trials

1718. Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

) of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx or larynx. Condition or disease Intervention/treatment Phase Head Neck Cancer Combination Product: Medpulser Electroporation with Bleomycin Procedure: Surgical Excision Phase 3 Detailed Description: Recurrent tumors in head and neck squamous cell carcinoma usually have a poor prognosis. In patients suitable for salvage surgery of their recurrent disease, the success rate for local control has been reported to be 40-50%. The surgical (...) of Function Status After Either Medpulser Electroporation With Intratumoral Bleomycin Therapy or Surgery in Patients With Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Base of the Tongue, Posterior Lateral Pharyngeal Wall, Hypopharynx, or Larynx That Have Failed Primary Curative Therapy Actual Study Start Date : November 2004 Actual Primary Completion Date : June 2007 Actual Study Completion Date : June 2007 Resource links provided by the National Library of Medicine related topics

2005 Clinical Trials

1719. Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

: Written informed consent. Aged between 18 and 80, inclusive. Karnofsky functional status >= 70% at the time of enrolment in study. Life expectancy of more than 3 months. Histologically confirmed diagnosis of oropharyngeal squamous cell carcinoma: base of tongue, vallecula, tonsil and tonsillar fossa and pillars, glossotonsillar sulcus, inferior surface of the soft palate, uvula and lateral and posterior oropharyngeal wall. Stage III or IV with no evidence of distant metastasis (IVA or IV B) Patients (...) Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2005 Clinical Trials

1720. Elective vs Therapeutic Neck Dissection in Treatment of Early Node Negative Squamous Carcinoma of Oral Cavity

, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Histologically proven T1 or T2 N0 M0 (clinical) squamous cell carcinoma of the buccal mucosa, lower alveolus, oral tongue and floor of mouth. Surgery is the preferred treatment and the primary tumor can be excised with clear margins via the per-oral route. No history of a prior malignancy in the head and neck region. No prior malignancy outside the head and neck region in the preceding 5 years (...) Elective vs Therapeutic Neck Dissection in Treatment of Early Node Negative Squamous Carcinoma of Oral Cavity Elective vs Therapeutic Neck Dissection in Treatment of Early Node Negative Squamous Carcinoma of Oral Cavity - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2005 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>